Dr. Carmen Familia, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,529 | 493 | 99.3% |
| Education | $84.99 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,715 | 95 | $0 (2024) |
| Novo Nordisk Inc | $1,289 | 54 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $970.97 | 17 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $838.12 | 59 | $0 (2024) |
| GlaxoSmithKline, LLC. | $721.15 | 37 | $0 (2024) |
| Amgen Inc. | $568.96 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $490.37 | 28 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $461.64 | 28 | $0 (2024) |
| Astellas Pharma US Inc | $368.65 | 13 | $0 (2024) |
| Esperion Therapeutics, Inc. | $339.14 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,494 | 71 | ABBVIE INC. ($273.16) |
| 2023 | $1,708 | 87 | Axsome Therapeutics, Inc. ($267.97) |
| 2022 | $2,055 | 98 | ABBVIE INC. ($518.51) |
| 2021 | $1,789 | 102 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($410.42) |
| 2020 | $675.16 | 32 | AbbVie Inc. ($172.27) |
| 2019 | $925.45 | 26 | Horizon Therapeutics plc ($168.07) |
| 2018 | $1,632 | 35 | Boehringer Ingelheim Pharmaceuticals, Inc. ($514.13) |
| 2017 | $1,335 | 43 | Horizon Pharma plc ($334.69) |
All Payment Transactions
494 individual payment records from CMS Open Payments — Page 20 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/04/2017 | PFIZER INC. | PREVNAR - 13 (Biological), TRUMENBA | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: VACCINES | ||||||
| 05/02/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Respiratory | ||||||
| 04/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PENNSAID | ||||||
| 03/23/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Diabetes | ||||||
| 03/21/2017 | Lilly USA, LLC | BASAGLAR (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 03/16/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/03/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: DIABETES | ||||||
| 03/02/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JENTADUETO (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DIABETES | ||||||
| 02/21/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Respiratory | ||||||
| 02/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), SYMBICORT | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/10/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/26/2017 | Horizon Pharma plc | VIMOVO (Drug), VIMOVO | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: VIMOVO | ||||||
| 01/19/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/13/2017 | Horizon Pharma plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: PENNSAID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 24 | $3,600 | $1,377 |
| 2022 | 3 | 62 | 78 | $10,800 | $5,347 |
| 2021 | 4 | 100 | 132 | $15,500 | $9,754 |
| 2020 | 4 | 104 | 132 | $12,540 | $6,583 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 24 | $3,600 | $1,377 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 45 | $6,750 | $2,503 | 37.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,200 | $2,469 | 77.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 17 | 17 | $850.00 | $373.94 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 66 | $9,600 | $4,845 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 25 | 25 | $3,850 | $3,822 | 99.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 14 | 18 | $900.00 | $571.14 | 63.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 23 | 23 | $1,150 | $515.66 | 44.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 54 | $6,750 | $3,033 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 17 | 17 | $2,550 | $2,296 | 90.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 36 | 42 | $2,100 | $784.74 | 37.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 19 | $1,140 | $469.48 | 41.2% |
About Dr. Carmen Familia, MD
Dr. Carmen Familia, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1770807992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmen Familia, MD has received a total of $11,614 in payments from pharmaceutical and medical device companies, with $1,494 received in 2024. These payments were reported across 494 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,529).
As a Medicare-enrolled provider, Familia has provided services to 281 Medicare beneficiaries, totaling 366 services with total Medicare billing of $23,061. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Bronx, NY
- Active Since 03/17/2010
- Last Updated 07/31/2015
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770807992
Products in Payments
- JARDIANCE (Drug) $907.09
- UBRELVY (Drug) $726.24
- Ozempic (Drug) $599.69
- XIFAXAN (Drug) $531.27
- RAYOS (Drug) $402.81
- Livalo (Drug) $393.51
- NEXLETOL (Drug) $339.14
- Trulance (Drug) $334.08
- Rybelsus (Drug) $331.73
- TRULANCE (Drug) $306.85
- LINZESS (Drug) $304.39
- QULIPTA (Drug) $289.74
- FARXIGA (Drug) $275.37
- ELIQUIS (Drug) $268.45
- Auvelity (Drug) $267.97
- CREON (Drug) $261.41
- Veozah (Drug) $215.74
- NUCALA (Biological) $215.70
- Otezla (Drug) $204.03
- ZENPEP (Drug) $185.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bronx
Dr. David Altschul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $394,687
Edvard Skripochnik, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $127,559
Dr. Cynthia Armand
Student in an Organized Health Care Education/Training Program — Payments: $68,024
Dr. Eric Woods, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,336
Ms. Kavita Gupta, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $31,772
Dr. Dmitriy Nevelev, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,107